This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Reduction in Mortality of Persons With High Blood Pressure, Including Mild Hypertension

Hypertension Detection and Follow-up Program Cooperative Group

JAMA. 1997;277(2):157-166.

Abstract
• The Hypertension Detection and Follow-up Program (HDFP), in a community-based, randomized controlled trial involving 10,940 persons with high blood pressure (BP), compared the effects on five-year mortality of a systematic antihypertensive treatment program (Stepped Care [SC]) and referral to community medical therapy (Referred [RC]). Participants, recruited by population-based screening of 158,906 people aged 30 to 69 years in 14 communities throughout the United States, were randomly assigned to SC or RC groups within each center and by entry diastolic blood pressure (DBP) (90 to 104, 105 to 114, and 115+ mm Hg). Over the five years of the study, more than two thirds of the SC participants continued to receive medication, and more than 50% achieved BP levels within the normotensive range, at or below the HDFP goal for DBP. Control of BP was consistently better for the SC than for the RC group. Five-year mortality from all causes was 17% lower for the SC group compared to the RC group (6.4 vs 7.7 per 100, P<.01) and 20% lower for the SC subgroup with entry DBP of 90 to 104 mm Hg compared to the corresponding RC subgroup (5.9 vs 7.4 per 100, P<.01). These findings of the HDFP indicate that the systematic effective management of hypertension has a great potential for reducing mortality for the large numbers of people with high BP in the population, including those with "mild" hypertension.

Author Affiliations
From the Hypertension Detection and Follow-up Program Cooperative Group, Division of Heart and Vascular Diseaaes, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

Footnotes
Reprint requests to Scientific Project Officer, Hypertension Detection and Follow-up Program, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Room 6C08, Federal Building, Bethesda, MD 20205.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Hypertension in Patients 80 Years of Age or Older
Beckett et al.
NEJM 2008;358:1887-1898.
ABSTRACT | FULL TEXT  

Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial
Qureshi et al.
BMJ 2007;335:1030-1030.
ABSTRACT | FULL TEXT  

The Deep-Breath Test as a Diagnostic Maneuver for White-Coat Effect in Hypertensive Patients
Augustovski et al.
J Am Board Fam Med 2004;17:184-189.
ABSTRACT | FULL TEXT